Cambridge Innovation Capital has returned after backing CMR Surgical's two-tranche $46m series A round in 2016 and 2017.

Ceres Nanosciences has added a $5.5m extension from investors including the LVG Seed Fund to help continue development of its diagnostics test for Lyme disease.

Pharmstandard and Access Industries-backed Neon Therapeutics has filed for a $115m initial public offering that will support a range of ongoing clinical trials.

Neuronetics has filed for an $86.3m initial public offering on Nasdaq that will offer exits to corporates Pfizer, General Electric and Ascension.

Cambridge spinout Crescendo Biologics has leveraged its transgenic protein discovery platform to license out an antibody to biopharmaceutical developer Zai Lab.

Rakhi Gibbons has become director of licensing at TLA after 12 years in the tech transfer business at University of Arizona and University of Michigan.

Northwestern is the third US university, after Vanderbilt and Johns Hopkins, to team up with Deerfield Management for an investment fund.